NCT01961297View on ClinicalTrials.gov

Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Spasmodic DysphoniaVoice Tremor
Interventions
DRUG

Sodium oxybate

Sodium oxybate

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Deafness and Other Communication Disorders (NIDCD)

NIH

lead

Kristina Simonyan

OTHER

NCT01961297 - Voice Tremor in Spasmodic Dysphonia: Central Mechanisms and Treatment Response | Biotech Hunter | Biotech Hunter